Skip to main content
. 2014 May 20;7:191–201. doi: 10.2147/IJNRD.S65158

Figure 5.

Figure 5

Output distribution for annual total cost (billion USD) of ESA and IV iron, assuming base rate values and 500,000 patients per year.

Notes: Median value of distribution is 5.127 (3.664–6.260) billion USD. No reductions to ESA or IV iron costs were assumed for ferric citrate usage. Distribution derived from 15,000 realizations.

Abbreviations: ESA, erythropoietin-stimulating agent; IV, intravenous; PDF, probability density function.